These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6749668)

  • 1. Platelet transfusions can induce transplantation tolerance.
    Claas FH; Blankert JJ; Ruigrok R; Moerel L
    Immunol Lett; 1982 Jul; 5(1):35-9. PubMed ID: 6749668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes.
    Kao KJ
    Blood; 1996 Dec; 88(11):4375-82. PubMed ID: 8943875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
    Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
    Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. II. Effect of pre-graft donor-specific blood transfusions in ALS-treated mice.
    Wood ML; Monaco AP
    Transplantation; 1984 Jan; 37(1):39-42. PubMed ID: 6364487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of immunogenicity of transfusion products.
    Deeg HJ
    Prog Clin Biol Res; 1986; 211():117-27. PubMed ID: 3515357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental model for preventing alloimmunization against platelet transfusions by pretreatment with antibody-coated cells.
    Süsal C; Terness P; Opelz G
    Vox Sang; 1990; 59(4):209-15. PubMed ID: 2293460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
    Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
    Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.
    Grana NH; Kao KJ
    Blood; 1991 Jun; 77(11):2530-7. PubMed ID: 1828180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
    J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions.
    Niimi M; Roelen DL; Witzke O; van Rood JJ; Claas FH; Wood KJ
    Transplantation; 2000 Feb; 69(3):411-7. PubMed ID: 10706052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of cardiac allografts in rats following the administration of heat-treated donor lymphocytes. A possible immunosuppressive role for class I major histocompatibility complex antigens.
    Baird MA; Bradley MP; Heslop BF
    Transplantation; 1986 Jul; 42(1):1-7. PubMed ID: 3523876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of platelet transfusions as preparation for kidney transplantation.
    Pouteil-Noble C; Betuel H; Raffaele P; Robert F; Dubernard JM; Touraine JL
    Transplantation; 1991 Apr; 51(4):777-81. PubMed ID: 1849672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of allograft survival in rats by blood transfusion to the donor.
    Heineman E; Marquet RL; Jeekel J
    Transplantation; 1983 Oct; 36(4):362-5. PubMed ID: 6353701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
    Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
    Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.